Motor activity and quantitative autoradiographic analysis of muscarinic receptors in the brain of rats subjected to the forced swimming test

Brain Research Bulletin

Volumn 42, Issue 2, 1997, Pages 133-139

  Carrizo, Edgardo ^a   Cano, Georgina ^b   Suarez Roca, Heberto ^a,b   Bonilla, Ernesto ^a,b  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Behavioral depression; Depression; Stress; 3H Quinuclidinyl benzilate

Indexed keywords

BRAIN RECEPTOR; MUSCARINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN; CAUDATE NUCLEUS; CONTROLLED STUDY; FORCED SWIMMING TEST; HIPPOCAMPUS; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PUTAMEN; RAT; TISSUE DISTRIBUTION;

EID: 17144454520     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00226-2     Document Type: Article

References (59)

1. 1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Press; 1994.
2. 2. Anisman, H. Time-dependent variations in aversively motivated behaviors: Nonassociative effects of cholinergic and catecholaminergic activity. Psychol. Rev. 82:359-385; 1975.
3. 3. Anisman, H.; Kokkinidis, L.; Sklar, L. S. Contribution of neurochemical change to stress-induced behavioral deficits. In: Cooper, S. J., ed. Theory in psychopharmacology. London: Academic Press; 1981:65-102.
4. 4. Anisman, H.; Pizzino, A.; Sklar, L. S. Coping with stress, norepinephrine depletion and escape performance. Brain Res. 191:583-588; 1980.
5. 5. Birdsall, N.; Buckley, N.; Doods, H.; Fukada, K.; Giachetti, A.; Hammer, R.; Kilbinger, H.; Lambrecht, G.; Mutscher, E.; Nathanson, W.; North, A.; Schwarz, R. Nomenclature for muscarinic receptor subtypes recommended by symposium. In: Levin, R. R.; Birdsall, N. J. M., eds. Subtypes of muscarinic receptors IV (Trends Pharmacol. Sci. Suppl.). Amsterdam: Elsevier Scientific; 1989:VII.
6. 6. Borsini, F.; Meli, A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology (Berlin) 94:147-160; 1988.
7. 7. Borsini, F.; Pulvirenti, L.; Samanin, R. Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioral "despairs" test in rats. Eur. J. Pharmacol. 110:253-256; 1985.
8. 8. Bunney, W. E.; Murphy, D. L. Strategies for the systematic study of neurotransmitter receptor function in man. In: Usdin, E.; Bunney, W. E., eds. Pre-and postsynaptic receptors. New York: Marcel Denker Inc.; 1975:283-312.
9. 9. Cervo, L.; Grignashi, G.; Samanin, R. Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: Involvement of a metabolite. Life Sci. 43:2095-2102; 1988.
10. 1A receptor agonist. Eur. J. Pharmacol. 144:223-229; 1987.
11. 11. Danysz, W.; Plaznik, A.; Kostowski, W.; Malatynska, E.; Järbe, T. C. U.; Hiltunen, A. J.; Archer, T. Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs. Pharmacol. Toxicol. 62:42-50; 1988.
12. 12. Davis, K. L.; Berger, P. A.; Hollister, L. E.; Defraites, E. Physostigmine in mania. Arch. Gen. Psychiatry 35:119-122; 1978.
13. 13. Dawson, T. M; Dawson, V. L.; Gage, F. H.; Fisher, L. J.; Hunt, M. A.; Wamsley, J. K. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): Normalization by fetal mesencephalic transplants. Brain Res. 540:145-152; 1991.
14. 14. Dawson, V. L.; Dawson, T. M.; Wamsley, J. K. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons. Brain Res. Bull. 25:903-912; 1990.
15. 15. DeSchaepdryver, A.; Preziosi, P.; Scapagnini, U. Brain monoamines and adrenocortical activation. Br. J. Pharmacol. 35:460-467; 1969.
16. 16. Dilsaver, S. C. Cholinergic mechanisms in depression. Brain Res. Rev. 11:285-316; 1986.
17. 17. Janowsky, D. S.; El-Yousef, M. K.; Davis, J. M.; Sekerke, H. J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet i:632-635; 1972.
18. 18. Janowsky, D. S.; El-Yousef, M. K.; Davis, J. M.; Sekerke, H. J. Parasympathetic suppression of mania symptoms by physostigmine in mania. Arch. Gen. Psychiatry 28:542-547; 1973.
19. 19. Janowsky, D. S.; Rish, S. C.; Judd, L.; Parker, D. C.; Kalin, N. H.; Huey, L. Y. Behavioral effects of physostigmine in affective disorder patients. In: Clayton, P. J.; Bennett, J. R., eds. Treatment of depression. New York: Raven; 1982.
20. 20. Janowsky, D. S.; Risch, S. C.; Parker, D.; Huey, L.; Judd, L. Increased vulnerability to cholinergic stimulation in affective-disorder patients. Psychopharmacol. Bull. 16(4):29-31; 1980.
21. 21. Kitada, Y.; Miyauchi, T.; Satoh, A.; Satoh, S. Effects of antidepressants in the rat forced swimming test. Eur. J. Pharmacol. 72:145-152; 1981.
22. 22. Kostowski, W.; Danysz, W.; Nowakowska, E. Studies on brain noradrenergic neurons in animal model for antidepressive activity. Psychopharmacol. Bull. 20(2):320-322; 1984.
23. 1A receptor agonist in animal models of depression and anxiety. Pharmacol. Toxicol. 71:24-30; 1992.
24. 24. Maj, J; Rogoacutez, Z.; Skuza, G.; Sowinska, H. The effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur. J. Neuropsychopharmacology 2:37-41; 1992.
25. 25. Marvinzon, J. C.; Lewin, A. H.; Skolnick, P. 1-Aminocyclopropanecarboxylic acid: A potent and selective ligand for the glycine modulatory site of the N-Methyl-D-aspartate receptor complex. J. Neurochem. 52:992-994; 1989.
26. 26. Munson, P. J.; Rodbard, D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239; 1980.
27. 27. Miura, H.; Naoi, M.; Nakahara, D.; Ohta, T.; Nagatsu, T. Changes in monoamine levels in mouse brain elicited by forced-swimming stress and the protective effect of a new monoamine oxidase inhibitor, RS-8359. J. Neural Transm. Gen. Sect. 94(3):175-187; 1993.
28. 28. Neilson, H. C.; Fleming, R. M. Effects of electroconvulsive shock and prior stress on brain amine levels. Exp. Neurol. 20:21-30; 1968.
29. 29. Overmier, J. B.; Seligman, M. E. P. Effects of inescapable shock on subsequent escape and avoidance learning. J. Comp. Physiol. Psychol. 63:23-33; 1967.
30. 30. Overstreet, D. H. Selective breeding for increased cholinergic function: Development of a new animal model of depression. Biol. Psychiatry 21:49-58; 1986.
31. 31. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates, 2nd ed. New York: Academic Press; 1986.
32. 32. Petty, F.; Sherman, A. D. Reversal of learned helplessness by imipramine. Commun. Psychopharmacol. 3:371-375; 1990.
33. 33. Plaznik, A.; Tamborska, E.; Hauptmann, M.; Bidzinski, A.; Kostowski, W. Brain neurotransmitter systems mediating behavioral deficits produced by inescapable shock treatment in rats. Brain Res. 447:122-132; 1988.
34. 34. Porsolt, R. D.; Anton, G.; Blavet, N.; Jalfre, M. Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47:379-391; 1978.
35. 35. Porsolt, R. D.; Le Pichon, M.; Jalfre, M. Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730-732; 1977.
36. 36. Prince, C. R.; Anisman, H. Acute and chronic stress effects on performance in a forced-swim task. Behav. Neural Biol. 42:99-119; 1984.
37. 37. Risch, S. C.; Cohen, R. M.; Janowsky, D. S.; Kalin, N. H.; Murphy, D. L. Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol. Science 209:1545-1546; 1980.
38. 38. Shanks, N.; Anisman, H. Strain-specific effects of antidepressants on escape deficits induced by inescapable shock. Psychopharmacology (Berlin) 99:122; 1989.
39. 39. Sherman, A. D.; Petty, F. Neurochemical basis of the action of antidepressants of learned helplessness. Behav. Neural Biol. 30:119-134; 1980.
40. 1A receptors. Neuropharmacology 32(4): 331-340; 1993.
41. 41. Skolnick, P.; Miller, R.; Young, A.; Boje, K; Trullas, R. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex. Psychopharmacology (Berlin) 107:489-496; 1992.
42. 42. Takahashi, R.; Tateishi, T.; Yoshida, H.; Nagayama, H.; Tachiki, K. H. Serotonin metabolism of animal model of depression. In: Haber, B.; Gabay, S.; Issidorides, M. R.; Alivisatos, S. G. A., eds. Serotonin: Current aspects of neurochemistry and function. New York: Plenum; 1981.
43. 43. Tamminga, C.; Smith, R. C.; Chang, S. Depression associated with oral choline. Lancet ii:905; 1976.
44. 44. Trullas, R.; Folio, T.; Young, A.; Miller, R.; Boje, K.; Skolnick, P. 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models. Eur. J. Pharmacol. 203:379-385; 1991.
45. 45. Trullas, R.; Skolnick, P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol. 185:1-10; 1990.
46. 3H-pirenzepine. Life Sci. 34:1395-1402; 1984.
47. 47. Wamsley, J. K.; Lewis, M. S.; Young, W. S., III; Kuhar, M. J. Autoradiographic localization of muscarinic cholinergic receptors in rat brainstem. J. Neurosci. 1(2):176-191; 1981.
48. 48. Watkins, J. C.; Olverman, H. J. Agonists and antagonists for excitatory amino acid receptors. Trends. Neurosci. 10:265-272; 1987.
49. 49. Watson, G. B.; Lanthorn, T. H. Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor associated glycine site. Neuropharmacology 29:727-730; 1990.
50. 50. Weiss, J. M.; Bailey, W. H.; Goodman, P. A.; Hoffman, L. F.; Ambrose, M. J.; Salman, S.; Charry, J. M. A model for neurochemical study of depression. In: Spiegelstein, M. Y.; Levy, A., eds. Behavioral models and the analysis of drug action. Amsterdam: Elsevier Scientific; 1982:195-223.
51. 51. Weiss, J. M.; Bailey, W. H.; Pohorecki, L. A.: Korzeniowski, D.; Grillone, G. Stress-induced depression of motor activity correlates with regional changes in brain norepinephrine but not in dopamine. Neurochem. Res. 5(1):9-22; 1980.
52. 52. Weiss, J. M.; Glazer, H. I. Effects of acute exposure to stressors on subsequent avoidance-escape behavior. Psychosom. Med. 37:499-521; 1975.
53. 53. Weiss, J. M.; Glazer, H. I.; Pohorecky, L. A. Coping behavior and neurochemical changes: An alternative explanation for the original 'learned helplessness' experiments. In: Serband, G.; Kling, A., eds. Animal models in human psychobiology. New York: Plenum Press; 1976:141-173.
54. 54. Weiss, J. M.; Goodman, P. A.; Losito, B. G.; Corrigan, S.; Charry, J. M; Bailey, W. H. Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Res. Rev. 3:167-205; 1981.
55. 55. Weiss, J. M.; Stone, E. A.; Harrel, N. Coping behavior and brain norepinephrine level in rats. J. Comp. Physiol. Psychol. 72:153-160; 1970.
56. 56. Wilner, P. The validity of animal models of depression. Psychopharmacology (Berlin) 83:1-16; 1984.
57. 57. Wong, E. H. F.; Kemp, J. A.; Priestley, T.; Knight, A. R.; Woodruff, G. N.; Iversen, L. L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 83:7104-7108; 1986.
58. 58. World Health Organization. The ICD-10 classification of mental and behavioral disorders: Clinical description and diagnostic guidelines. Geneva: WHO; 1992.
59. 59. Yamamura, H. I.; Snyder, S. H. Muscarinic Cholinergic binding in rat brain. Proc. Natl. Acad. Sci. USA 71(5):1725-1729; 1974.